(Reuters) – AstraZeneca Plc has sold its stake in Moderna Inc for more than $1 billion after the American biotechnology company’s shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.
The report added that it was not clear when and over what period AstraZeneca sold its full holding in Moderna.
(Reporting by Maria Ponnezhath in Bengaluru; editing by Jonathan Oatis)
